Bloomberg Law
Health Law & Business News

Obamacare Alternative Hit With Crackdown by Biden Agencies

The Biden administration plans to issue a final rule on Thursday to curb the sale and availability of “short-term limited-duration insurance” plans, which critics say provide low-cost, but low-quality, coverage that skirts consumer protections in the Affordable Care Act.

Novo’s $1,000 Diabetes Drug Can Be Made for Under $5 a Month

Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity.

Landmark Washington Health Data Privacy Law Creates Suit Risks

Businesses dealing with health-related data in Washington state will be subject to new litigation and enforcement risks next week, as a far-reaching health privacy law takes effect.

Ninth Circuit Slams Idaho AG for Not Defending Abortion Letter

A panel of federal appeals court judges slammed the Idaho attorney general’s lawyer for failing to argue that a lawsuit brought by abortion providers is wrong on the merits.

AstraZeneca Sues to Block Arkansas Contract Pharmacy Law

Pharmaceutical giant AstraZeneca is seeking to block an Arkansas law that prohibits manufacturers from placing restrictions on pharmacies that take part in a federal drug discount program.

PRACTITIONER INSIGHTS

View More Insights

Latest Stories

Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price

Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug <-bsp-bb-link state="{"bbHref":"bbg://screens/nse%20ozempic%20bn","_id":"0000018e-8603-dd73-a18e-c7070a500003","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity.

Zepbound in Short Supply at Amazon, Rite Aid, Pharmacies Confirm

<-rte-company state="{"_id":"0000018e-8614-dd73-a18e-c717fb660000","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Rite Aid Corp. and Amazon Pharmacy confirmed that Eli Lilly & Co.’s new weight-loss drug Zepbound is in short supply, as patient, pharmacist and doctor complaints mount.

J&J to Pay $75 Million to Settle $6 Billion Baby Powder Suit

Johnson & Johnson will pay $75 million to settle a consumer protection lawsuit filed by Mississippi over the company’s talc-based baby powder, according to people familiar with the matter, resolving litigation in which the state had sought as much as $6 billion.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & Practice Environment & Energy Report Environmental, Social & Governance (ESG) The United States Law Week
  • Business & Practice
  • Environment & Energy Report
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

US ‘Kleptocapture’ Group Seeks Russia Sanction Evaders Worldwide

Latvian authorities have arrested and plan to extradite to the US a local man over his work for a Kansas-based company in the alleged smuggling of avionics equipment through third countries destined for Russia, in violation of US export controls, the Justice Department said Wednesday.

Home Depot Bets $18 Billion on Expanding Battle for the Pro

<-bsp-bb-link state="{"bbHref":"bbg://securities/HD%20US%20Equity/MA%20MADL","_id":"0000018e-8614-dd73-a18e-c717fb620000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Home Depot Inc. is making its biggest <-bsp-bb-link state="{"bbDocId":"SB1YGATVI5MQ","_id":"0000018e-8614-dd73-a18e-c717fb620001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">acquisition ever to win over more professional contractors as the company looks beyond its do-it-yourself roots to revive growth.

Covid Vaccine & Personal Data: Does HIPAA Still Matter?